BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Littorin N, Ahl J, Uddén F, Resman F, Riesbeck K. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county. BMC Infect Dis 2016;16:407. [PMID: 27514843 DOI: 10.1186/s12879-016-1750-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ubukata K, Morozumi M, Sakuma M, Takata M, Mokuno E, Tajima T, Iwata S; AOM Surveillance Study Group. Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates After Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children. Pediatr Infect Dis J 2018;37:598-604. [PMID: 29474258 DOI: 10.1097/INF.0000000000001956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
2 Littorin N, Rünow E, Ahl J, Resman F, Riesbeck K. Decreased prevalence of Moraxella catarrhalis in addition to Streptococcus pneumoniae in children with upper respiratory tract infection after introduction of conjugated pneumococcal vaccine: a retrospective cohort study. Clin Microbiol Infect 2021;27:630.e1-6. [PMID: 32360778 DOI: 10.1016/j.cmi.2020.04.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yang R, Sabharwal V, Shlykova N, Okonkwo OS, Pelton SI, Kohane DS. Treatment of Streptococcus pneumoniae otitis media in a chinchilla model by transtympanic delivery of antibiotics. JCI Insight 2018;3:123415. [PMID: 30282835 DOI: 10.1172/jci.insight.123415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
4 Riesbeck K. Hemolytic Uremic Syndrome Associated With Pneumococci in Children—An Elusive Mystery Now Explained? The Journal of Infectious Diseases 2018;217:341-3. [DOI: 10.1093/infdis/jix306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Avarvand AY, Halaji M, Zare D, Hasannejad-Bibalan M, Ebrahim-Saraie HS. Prevalence of Invasive Streptococcus pneumoniae Infections among Iranian Children: A Systematic Review and Meta-Analysis. Iran J Public Health 2021;50:1135-42. [PMID: 34540734 DOI: 10.18502/ijph.v50i6.6412] [Reference Citation Analysis]
6 Janouková M, Straw ML, Su Y, Riesbeck K. Gene Expression Regulation in Airway Pathogens: Importance for Otitis Media. Front Cell Infect Microbiol 2022;12:826018. [DOI: 10.3389/fcimb.2022.826018] [Reference Citation Analysis]
7 Leigh-de Rapper S, van Vuuren SF. Odoriferous Therapy: A Review Identifying Essential Oils against Pathogens of the Respiratory Tract. Chem Biodivers 2020;17:e2000062. [PMID: 32207224 DOI: 10.1002/cbdv.202000062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
8 Marchisio P, Bortone B, Ciarcià M, Motisi MA, Torretta S, Castelli Gattinara G, Picca M, Di Mauro G, Bonino M, Mansi N, Varricchio A, Marseglia GL, Cardinale F, Villani A, Chiappini E; the Italian Panel for the Management of Acute Otitis Media in Children. Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Prevention. Pediatric Infectious Disease Journal 2019;38:S22-36. [DOI: 10.1097/inf.0000000000002430] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hu T, Podmore B, Barnett R, Beier D, Galetzka W, Qizilbash N, Haeckl D, Weaver J, Boellinger T, Mihm S, Petigara T. Incidence of acute otitis media in children < 16 years old in Germany during 2014-2019. BMC Pediatr 2022;22:204. [PMID: 35418046 DOI: 10.1186/s12887-022-03270-w] [Reference Citation Analysis]
10 Bergenfelz C, Hakansson AP. Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies. Curr Otorhinolaryngol Rep 2017;5:115-24. [PMID: 28616365 DOI: 10.1007/s40136-017-0152-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
11 Uddén F, Rünow E, Slotved HC, Fuursted K, Ahl J, Riesbeck K. Characterization of Streptococcus pneumoniae detected in clinical respiratory tract samples in southern Sweden 2 to 4 years after introduction of PCV13. J Infect 2021;83:190-6. [PMID: 34062179 DOI: 10.1016/j.jinf.2021.05.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Alderson MR, Murphy T, Pelton SI, Novotny LA, Hammitt LL, Kurabi A, Li JD, Thornton RB, Kirkham LS. Panel 8: Vaccines and immunology. Int J Pediatr Otorhinolaryngol 2020;130 Suppl 1:109839. [PMID: 31948716 DOI: 10.1016/j.ijporl.2019.109839] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
13 Yang R, Okonkwo OS, Zurakowski D, Kohane DS. Synergy between chemical permeation enhancers and drug permeation across the tympanic membrane. J Control Release 2018;289:94-101. [PMID: 29932959 DOI: 10.1016/j.jconrel.2018.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
14 Karppinen S, Toivonen L, Schuez-havupalo L, Teros-jaakkola T, Waris M, Auranen K, Palmu AA, Peltola V. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age. Vaccine 2019;37:2935-41. [DOI: 10.1016/j.vaccine.2019.04.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Shpagina LA, Kotova OS, Shpagin IS, Loktin EM, Rukavitsyna AA, Kuznetsova GV, Kamneva NV, Laletina MA. Efficacy of 13-valent pneumococcal conjugate vaccine in healthcare workers. Terapevticheskii arkhiv 2018;90:55-61. [DOI: 10.26442/terarkh201890114-61] [Reference Citation Analysis]
16 Johansson Kostenniemi U, Palm J, Silfverdal SA. Reductions in otitis and other respiratory tract infections following childhood pneumococcal vaccination. Acta Paediatr 2018. [PMID: 29603797 DOI: 10.1111/apa.14345] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Andrade DC, Borges IC, Bouzas ML, Oliveira JR, Käyhty H, Ruuskanen O, Nascimento-Carvalho C. Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage. Infect Dis (Lond) 2018;50:705-13. [PMID: 29688138 DOI: 10.1080/23744235.2018.1463451] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
18 Edmondson-Jones M, Dibbern T, Hultberg M, Anell B, Medin E, Feng Y, Talarico C. Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions. Hum Vaccin Immunother 2021;:1-9. [PMID: 34319865 DOI: 10.1080/21645515.2021.1942712] [Reference Citation Analysis]
19 Edmondson-Jones M, Dibbern T, Hultberg M, Anell B, Medin E, Feng Y, Talarico C. The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions. Hum Vaccin Immunother 2021;17:517-26. [PMID: 32574101 DOI: 10.1080/21645515.2020.1775455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]